Cambridge Antibody Technology Group Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (557)	12/21/2004 12:00:41 PM
From: keokalani'nui	of 625

>>Back to catg, I don't get the Abbott case. Hard to see why abt thought they would win or catg would settle. << It's what happens after a huge acquisition. --No personal relationship with CAT. --No one with first person history of the original negotiations. --US business practices are not honorable or civil, and transaction costs are the coin of the realm. --Internal legal departments and outside counsel are told to find a particular answer, instead of being asked to use best judgment of what is the most correct answer. Instead of managing risk which is their role, they are told to find new revenue opportunties in agreements already in place. --Also, multi-layered bureaucratic decision making. And everyone with institutional knowledge has been RIF'd, because those people are expensive to have around and they are like parents always saying that something has already been tried and why is not really a very good idea. --Finally, US executives are promoted/rewarded based on agressiveness, not wisdom or foresight. Just my POV. ;-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next